Evaluating Digital Therapeutics for Midlife Women’s Menopausal Symptoms: A Synthesis of Recent Randomized Controlled Trials

Highlights

  • Digital therapeutics like the Caria app demonstrate significant reductions in vasomotor symptoms (hot flashes) and behavioral health issues (depression, sleep disturbance) among women in midlife during menopause.
  • Randomized controlled trials (RCTs) consistently show digital cognitive-behavioral therapy (CBT) platforms improve depressive symptoms and self-management in diverse populations beyond menopause, including postpartum depression and social anxiety disorders.
  • High patient engagement and adherence are achievable with app-based interventions incorporating personalized content and coaching, though long-term maintenance of benefits requires further research.
  • Systematic reviews confirm digital behavioral activation and CBT interventions reduce depressive symptoms in the short to midterm, supporting integration into clinical care pathways with attention to cultural adaptation and accessibility.

Background

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply